Newsletter

RisingPennyStocks does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before investing. RisingPennyStocks is not a licensed financial advisor. This is a paid for marketing newsletter which will state compensation, if any, for the specific company being marketed in the disclaimer at the end of this newsletter, this is not a solicitation or recommendation to buy or sell securities. RisingPennyStocks is now fully owned and operated by Freedom Ventures, LLC.

Tomorrow's Alert is
Madison Explorations Inc. - MDEX

Hello again Trader Nation!

We’ll get right to the point because we’re as equally excited as you to get the word out on MDEX!

MDEX (Madison Explorations Inc.) – Current PPS - $.1299

MDEX is in one of the hottest industries to ever hit the OTC markets. 

We’re talking about the marijuana industry! 

MDEX is a leader in smokeless cannabinoid delivery technology.

MDEX could possibly see some real impressive gains real soon and we want to offer our readers a good look at it and its possible advantages. 

After reading this newsletter, you might also come to the conclusion that MDEX is an underpriced opportunity.  

The stock could appear as an enormous ground-floor opportunity into the legal marijuana sector!

The Company is continuing to expand upon the proven smokeless delivery system CannaStrips with a series of additional smokeless delivery technologies.

MDEX announced in its most recent press release a corporate update to their shareholders, which has produced a real specific concern around the community and plenty of positive interest all around. 

Here’s part of that report that has this selection boiling over with beneficial potential. 

SALT LAKE CITY, UTAH--(Marketwired - Sep 26, 2014) - Madison Explorations, Inc., (MDEX) (the "Company") a leader in smokeless cannabinoid delivery technology, announces that it's new CEO, Mr. Brent Inzer, today has issued a corporate update to the MDEX shareholders:

As CEO of Madison Explorations, Inc. I would like to take this opportunity to update our shareholders on the current status of our Company and outline both our short and long term goals for the Company.

MDEX is uniquely positioned to become the leading smokeless cannabinoid technology provider, establishing a strong reputation for the highest quality, dosage reliability and formulation innovation. The Company is continuing its development and improvement of the products, production methods and formulations for its proprietary technology "CannaStrips" and is in advanced development of a number of additional smokeless delivery systems designed specifically for smokeless cannabinoid therapy.

Our immediate goal is to implement the Company's business development strategy. The Company intends to license the CannaStrips technology, which will include proprietary equipment being leased to CannaStrip's licensees that have State approved marijuana production facilities and/or dispensaries. We intend to focus initially on California, Colorado and Washington State. The Company has begun discussions with several licensed marijuana facilities and has received strong interest for our smokeless technology CannaStrips.

The Company is continuing to expand upon the proven smokeless delivery system CannaStrips with a series of additional smokeless delivery technologies. We are very excited about some of the initial beta tests of these technologies. The Company will continue to deliver cannabinoids variations for the clinical treatment of sleep disorders, seizures, cancer symptoms and pain therapy. With the advent of recreational use, the need for precise dosage and accurate categorizing of cannabis strains and possible effects is essential for responsible use of cannabis products. The Company has begun formulations for recreational users with these expectations in mind and all products produced with our technologies will be tested both in our lab and independently verified by outside laboratories for THC concentrations, cannabinoid consistency and acute dosage.

To read that full report, click here:
http://finance.yahoo.com/news/madison-explorations-inc-ceo-announces-113000560.html

BUSINESS SUMMARY
(MDEX - Madison Explorations Inc. / PPS. -$.1299)

Here’s a quick message from Sept 25 from their CEO:

Madison Explorations, Inc., (MDEX) (the "Company") a leader in smokeless cannabinoid delivery technology, announces the launch of its newly developed website, http://cannabinoidstrips.com.

Brent Inzer, CEO of the Company, commented: "We are excited to see our new website going live. We are certain that our web site will allow us to bring awareness about our CannaStrips technology and contribute our experience and resources to the general public".

CannaStrips brings to patients Medical Cannabis in the form of a sub-lingual strip that quickly dissolves under the tongue delivering pure cannabis to the patient without the negative effects of smoking. One of the most technologically advanced delivery systems available today! Precisely measured dosage that is safe and highly efficient. Great taste that freshens breath too! Relieves pain and enhances relaxation without compromising mental alertness.

CannaStrips are the result of lengthy research and development. CannaStrips are a safer and healthier alternative to smoking and has had an amazing reception throughout the medicinal cannabis community.

MARKET OUTLOOK

U.S. retail cannabis sales will rise more than five-fold over the next five years, from an estimated $2.2-$2.6 billion in 2014 to $7.4-8.2 billion in 2018, according to new financial data released today in the 2014 edition of the Marijuana Business Factbook.

Although the 2014 estimated sales are right in line with predictions from last year’s edition of the Factbook, the 2018 forecast has risen by roughly $2 billion.

Medicines today are expected to be of known composition and quality. Even in cases where marijuana can provide relief of symptoms, the crude plant mixture does not meet this modern expectation. The future of medical marijuana lies in classical pharmacological drug development, and indeed there has been a resurgence of scientific, as well as public, interest in the therapeutic applications of cannabinoids. 

After an initial burst of scientific activity in the 1970s, today's renewed interest has been fueled by major scientific discoveries discussed in previous chapters: the identification and cloning of endogenous cannabinoid receptors, the discovery of endogenous substances that bind to these receptors, and the emergence of synthetic cannabinoids that also bind to cannabinoid receptors. These scientific accomplishments have propelled interest in developing new drugs that can treat more effectively or more safely the constellation of symptoms for which cannabinoids might have therapeutic benefit. Through the process of what is referred to as "rational drug design", scientists manipulate the chemical structures of known cannabinoids to design better therapeutic agents. Several new cannabinoids are being developed for human use, but none has reached the stage of human testing in the United States.

INVESTOR HIGHLIGHTS

MDEX is a leader in smokeless cannabinoid delivery technology.

MDEX appears to be a very underpriced opportunity with a lot of upside. 

MDEX is in the smoldering-hot marijuana industry!

MDEX could see some impressive gains very soon.

MDEX should be given your attention immediately so start your research now and see the possibilities with your own eyes. 

In addition to doing your own research on MDEX, also remember to never invest more than you can afford to lose. The OTC markets are fast and volatile and anything can happen. 

***Please sign up for my FREE Text Message list***

Emails tend to take too long to be received and my alerts immediately start gaining momentum when the market opens.  By signing up to my text messages you will receive my alerts at 9:30am EST every time! 

Just text the words “StockPicks” to “95577” and start
 Receiving alerts immediately on your phone. 

Dear Reader: Sadly, there is no magic formula to getting rich. Success in the stock market can only come from the best prospects for price appreciation and can only be achieved through proper and rigorous research and analysis. The opinions in this e-newsletter are just that, opinions of the authors. Information contained herein, while believed to be correct, is not guaranteed as accurate. Almost all the stocks I discuss in my newsletter I have been paid to talk about since that is the way this site makes money. I will always include any compensation I have or expect to receive if that happens to make a difference to you. Investing in stocks (especially penny stocks) involves high risks and you can lose all of money, so do not invest with money you cannot afford to lose. 

The below Disclaimer is to be read in full:

Disclaimer

RisingPennyStocks is now fully owned and operated by Freedom Ventures, LLC.
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies.  By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on EOD or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices.
Release of Liability: Through use of this website viewing or using you agree to hold RisingPennyStocks, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may suffer. The information contained herein is based on sources, which we believe to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Please be advised that RisingPennyStocks is often compensated for issuing press releases, profiles or opinions concerning particular companies, its opinion is therefore biased and you should consider the factor when evaluating RisingPennyStocks statements regarding a company. RisingPennyStocks officers and directors do not own any shares of the mentioned company(s). When RisingPennyStocks receives free or restricted trading shares as a compensation for a profiled company, RisingPennyStocks may sell part or all of such shares during the period in which RisingPennyStocks is performing such services. RisingPennyStocks will disclose how many and what type of shares we have been compensated if we do receive shares or buy shares of a profiled company. RisingPennyStocks will also disclose any compensation.
RisingPennyStocks, which is now fully owned and operated by Freedom Ventures, LLC. has been compensated Eighteen Thousand Five Hundred Dollars Cash via Bank Wire by a Third Party, Microcap Innovations, LLC, for this one day marketing and awareness campaign on MDEX ending on October 1st, 2014. This compensation/expected compensation is a major conflict of interest in our ability to be unbiased. Therefore, this newsletter should be read as a commercial advertisement only. The third party, company, or their affiliates will liquidate shares, which has the potential to hurt share prices. Notice of Stock Price Movements and Volatility Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. A company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results.  We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct.
RisingPennyStocks encourages readers and investors to supplement the information in this report with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and RisingPennyStocks makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Neither RisingPennyStocks, nor any of its affiliates are not registered investment advisors or a broker dealer. Please read our FULL Disclaimer at http://www.risingpennystocks.com/disclaimer .

Stocks covered:	Compensation:	Avg $ Volume for Period:
MDEX	$18500	12381
Max Profit: 16.67 %	Gain at close: 8.25 %
*We think that this promoter is a part of a group of promoters.

Newsletter

MDEX-cellent Appears Ready For Action! Sep 30, 2014 16:19